Jörg Westermann

BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation

Simon Raffel, Mattia Falcone, Niclas Kneisel et al. · Nature · 2017 · 353 citations

Life Sciences, Genetics, Molecular Biology +14

Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

Richard F. Schlenk, Daniela Weber, Walter Fiedler et al. · Blood · 2018 · 288 citations · Full text

Medicine, Oncology, Pharmacology +12

Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)

Gabriele Nagel, Daniela Weber, Ella Fromm et al. · Annals of Hematology · 2017 · 170 citations · Full text

Medicine, Genetics, Hematology +14

Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group

Frank G. Rücker, Mridul Agrawal, Andrea Corbacioglu et al. · Blood · 2019 · 118 citations · Full text

Medicine, Hematology, Oncology +16

BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features

Nina Rosa Neuendorff, Thomas Burmeister, Bernd Dörken et al. · Annals of Hematology · 2016 · 92 citations

Medicine, Hematology, Oncology +14